Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/18259610

Download in:

View as

General Info

PMID
18259610